Startup | May 18, 2022
Mental wellness startup Lissun targets phygital presence in over 25 cities this year
The centres will be located in Tier I and Tier II cities
The centres will be located in Tier I and Tier II cities
Partners with GITAM University to train 27 employees through a 10-day HR module and make them future-ready
Brazil has the 4th largest pet market in the world with an estimated market size of BRL 1.8 billion, growing annually at 16%
Intox is a GLP certified pre-clinical contract research organization with its test facilities in Pune
Solara Active Pharma Sciences has reported consolidated financial results for the period ended September 30, 2021.
This robust performance is a testimony of the company's agility, resilience and strong execution capabilities during these difficult times
India is dependent upon China and other countries for a lot of Key Starting Materials (KSM) for their bulk drug needs.
The company has an outlay of Rs 120-140 crore as R & D expense for FY 22
The company has already embarked upon significant expansion in Turkey
In an exclusive interview with Rahul Koul of Indian Chemical News, Priyanka Chigurupati, Executive Director, Granules Pharmaceuticals Inc. USA shared details about the company's performance, R&D initiatives, Capex plan, CSR, and future outlook. Excerpts of the interview:
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)